A086060 Stock Overview
Engages in the manufacture and sale of feed additives and functional food in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
GeneBioTech Co. ,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,130.00 |
| 52 Week High | ₩5,120.00 |
| 52 Week Low | ₩3,325.00 |
| Beta | 0.54 |
| 11 Month Change | 6.03% |
| 3 Month Change | 3.25% |
| 1 Year Change | -0.60% |
| 33 Year Change | -27.92% |
| 5 Year Change | 0.36% |
| Change since IPO | -51.47% |
Recent News & Updates
Market Cool On GeneBioTech Co. ,Ltd's (KOSDAQ:086060) Earnings
Aug 12
We Like The Quality Of GeneBioTech Ltd's (KOSDAQ:086060) Earnings
Mar 22Recent updates
Market Cool On GeneBioTech Co. ,Ltd's (KOSDAQ:086060) Earnings
Aug 12We Like The Quality Of GeneBioTech Ltd's (KOSDAQ:086060) Earnings
Mar 22Read This Before Buying GeneBioTech Co. ,Ltd (KOSDAQ:086060) For Its Dividend
Apr 15Should GeneBioTech Ltd (KOSDAQ:086060) Be Disappointed With Their 90% Profit?
Mar 18Here's Why Genebiotech (KOSDAQ:086060) Has A Meaningful Debt Burden
Feb 17
How Does Genebiotech Co., Ltd. (KOSDAQ:086060) Fare As A Dividend Stock?
Jan 10Is Genebiotech (KOSDAQ:086060) A Risky Investment?
Nov 19Shareholder Returns
| A086060 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 5.8% | 1.3% | 4.1% |
| 1Y | -0.6% | 35.8% | 5.1% |
Return vs Industry: A086060 underperformed the KR Biotechs industry which returned 35.8% over the past year.
Return vs Market: A086060 underperformed the KR Market which returned 5.1% over the past year.
Price Volatility
| A086060 volatility | |
|---|---|
| A086060 Average Weekly Movement | 4.0% |
| Biotechs Industry Average Movement | 9.5% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A086060 has not had significant price volatility in the past 3 months.
Volatility Over Time: A086060's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 39 | Chan-Ho Lee | www.genebiotech.co.kr |
GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea.
GeneBioTech Co. ,Ltd Fundamentals Summary
| A086060 fundamental statistics | |
|---|---|
| Market cap | ₩35.56b |
| Earnings (TTM) | ₩2.60b |
| Revenue (TTM) | ₩80.27b |
13.7x
P/E Ratio0.4x
P/S RatioIs A086060 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A086060 income statement (TTM) | |
|---|---|
| Revenue | ₩80.27b |
| Cost of Revenue | ₩66.58b |
| Gross Profit | ₩13.68b |
| Other Expenses | ₩11.08b |
| Earnings | ₩2.60b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 302.49 |
| Gross Margin | 17.05% |
| Net Profit Margin | 3.24% |
| Debt/Equity Ratio | 27.6% |
How did A086060 perform over the long term?
See historical performance and comparison